VALN

5.1603.82%
JJ

Juan-Carlos Jaramillo

Chief Medical Officer

Dr. Juan-Carlos Jaramillo, M.D., serves as Chief Medical Officer Board at Valneva SE since October 01, 2020 and served as Member of the Management since October 01, 2020 until December 20, 2023. Prior to joining us, Dr. Jaramillo served as Senior Vice President, Market Access & Medical Affairs and then as Senior Vice President, Head of Global Market Access & Pricing at Daiichi Sankyo, GmbH from April 2013 to September 2020. Prior to Daiichi Sankyo, Dr. Jaramillo served as Senior Vice President, Medical Affairs & Clinical Development at Grünenthal, Inc. and prior to that held a variety of positions at GlaxoSmithKline plc. He served as Head of Global Market Access & Pricing at Daiichi Sankyo Co. He has a broad international experience, strong expertise in Medical Affairs and Clinical Development that includes vaccines, as well as Global Market Access. Due to his diverse pharma exposure, he has an in-depth business understanding and a strong track-record of success across a wide range of settings, therapeutic areas and geographies. He has worked in various pharmaceutical/biotech organizations, including GlaxoSmithKline and Grünenthal. Dr. Jaramillo received his M.D. and B.S. in Pre-Medicine from Universidad Central Del Este.

Positions